MedTrace Logo

Community Interventional Trial (CITFOMIST)

NCT02035423 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6000

Last updated 2014-01-14

No results posted yet for this study

Summary

The cluster randomized trial (CITFOMIST) was conducted on 15-19-year old guidance and high school students of both genders from different districts of Tehran, the Iranian capital, in winter 2011. The 36 schools enrolled in this study were randomly assigned to receive one of the three groups of milk -- whole milk, milk that contained 600 IU Vit D/1000cc, milk that contained 1000 IU Vit D /1000cc -- for a 30-day period. In order to study the effect of vitamin D-fortified milk on the circulating concentrations of 25(OH)D, a serum vitamin D levels were checked in a subgroup before and after the intervention.

Conditions

  • Vitamin D Deficiency

Interventions

DIETARY_SUPPLEMENT

120 IU milk

Daily consumption of milk fortified with 120 IU vitamin D

DIETARY_SUPPLEMENT

200 IU Milk

Daily Consumption of milk fortified with 200 IU vitamin D

DIETARY_SUPPLEMENT

Non-Fortified Milk

Daily consumption of non-fortified milk

Sponsors & Collaborators

  • UNICEF

    collaborator OTHER

  • Tehran University of Medical Sciences

    lead OTHER

Principal Investigators

  • Patricia Khashayar · Endocrinology and Metabolism Research Institute

  • Abbasali Keshtkar · Endocrinology and Metabolism Research Institute

  • Bagher Larijani · Endocrinology and Metabolism Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-03-31
Completion
2011-06-30

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02035423 on ClinicalTrials.gov